Eton Pharmaceuticals, Inc. Public Float
Eton Pharmaceuticals, Inc. (ETON) had Public Float of $360.60 million as of 2025-06-30, per its 10-K filed 2026-03-19.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-19
- 2025-06-30: Entity Public Float $360.60M.
- 2024-06-30: Entity Public Float $80.20M.
- 2023-06-30: Entity Public Float $84.70M.
- 2022-06-30: Entity Public Float $51.50M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $360.60M 10-K · filed 2026-03-19 |
| 2024-06-30 | $80.20M 10-K · filed 2025-03-18 |
| 2023-06-30 | $84.70M 10-K/A · filed 2024-03-22 |
| 2022-06-30 | $51.50M 10-K · filed 2023-03-16 |
| 2021-06-30 | $108.80M 10-K · filed 2022-03-16 |
| 2020-06-30 | $64.20M 10-K · filed 2021-03-16 |
| 2019-06-30 | $96.60M 10-K · filed 2020-03-05 |
| 2018-06-30 | $0.00 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |